A 2015 roadmap for the management of hepatitis C virus infections in Asia
about
Dual sofosbuvir and ribavirin therapy for chronic hepatitis C infection.Daclatasvir/Asunaprevir/Beclabuvir (DCV-TRIO), All-Oral, Fixed-Dose Combination for Patients With Chronic HCV Genotype 1.Urgency to treat patients with chronic hepatitis C in Asia.Cost-effectiveness of strategy-based approach to treatment of genotype 1 chronic hepatitis C.Elbasvir/grazoprevir in Asia-Pacific/Russian participants with chronic hepatitis C virus genotype 1, 4, or 6 infection.
P2860
A 2015 roadmap for the management of hepatitis C virus infections in Asia
description
2015 nî lūn-bûn
@nan
2015 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
A 2015 roadmap for the management of hepatitis C virus infections in Asia
@ast
A 2015 roadmap for the management of hepatitis C virus infections in Asia
@en
A 2015 roadmap for the management of hepatitis C virus infections in Asia
@nl
type
label
A 2015 roadmap for the management of hepatitis C virus infections in Asia
@ast
A 2015 roadmap for the management of hepatitis C virus infections in Asia
@en
A 2015 roadmap for the management of hepatitis C virus infections in Asia
@nl
prefLabel
A 2015 roadmap for the management of hepatitis C virus infections in Asia
@ast
A 2015 roadmap for the management of hepatitis C virus infections in Asia
@en
A 2015 roadmap for the management of hepatitis C virus infections in Asia
@nl
P2860
P1476
A 2015 roadmap for the management of hepatitis C virus infections in Asia
@en
P2093
Seng Gee Lim
Yock Young Dan
P2860
P304
P356
10.3904/KJIM.2015.30.4.423
P407
P5008
P577
2015-07-01T00:00:00Z